Global Transdermal Drug Patches Market

Transdermal Drug Patches Comprehensive Study by Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, Others), Application (Hypertension, Contraception, Analgesia, Smoking Cessation, Angina, Hormone Replacement), Distribution Channel (Online, Offline), End User (Home Care Settings, Hospitals & Clinics, Others) Players and Region - Global Market Outlook to 2024

Transdermal Drug Patches Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Transdermal Drug Patches Market Overview:
The transdermal drug patches are designed to release small quantities of drugs into the bloodstream over a long period of time. The drug is engrossed from the patch, through the outer layers of skin, and into deeper layers and it is absorbed into the bloodstream and circulated through the body. Transdermal patch drugs contain pain relievers, nicotine, hormones, and drugs to treat angina and motion sickness. If the patch is broken, cut open, or chewed on, if too many are worn, or if a child has an adult patch on, overdoses can happen. Several people benefit from drugs that are absorbed slowly and regularly and some find it difficult to swallow pills. However, this type of patch is actually a sophisticated drug delivery system. Some of the key players profiled in the study are Noven Pharmaceuticals, Inc. (United States), Mylan (United States), Novartis (Switzerland), Johnson & Johnson (United States), Agile Therapeutics (United States), Accrux Ltd. (Australia), Teikoku Pharma USA (United States), Immune Pharmaceuticals (United States), Hercon Pharmaceuticals (United States) and Pocono Coated Products (United States).

On the basis of geography, the market of Transdermal Drug Patches has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Transdermal Drug Patches market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Home Care Settings will boost the Transdermal Drug Patches market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Prevalence of Chronic Diseases
  • Ease of Administration of Drugs

Market Trend
  • Increasing Advantages over the Oral and Ingesting Treatments

Restraints
  • Concerns Regarding Drug Failure

Opportunities
  • Technological Advancements in Transdermal Drug Delivery

Challenges
  • Technical Barriers Related to Skin Irritation




Leading key players of transdermal drug patches are focusing on strategic partnerships, acquisitions, new product launches to improve their products & services and also focusing on increasing their client base to strengthen market position.

Target Audience:
Manufacturers of Transdermal Drug Patches, Suppliers of Raw Materials, Wholesalers, Distributors, and Retailers of Transdermal Drug Patches, Healthcare Industry, Governmental Bodies and Research Organizations

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Transdermal Drug Patches market on the basis of product [Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch and Others] , application [Hypertension, Contraception, Analgesia, Smoking Cessation, Angina and Hormone Replacement], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Transdermal Drug Patches market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Transdermal Drug Patches industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are DURECT Corporation (United States) and Xel Pharmaceuticals (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Transdermal Drug Patches market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.

Report Objectives / Segmentation Covered

By Type
  • Fentanyl Transdermal Patch
  • Nicotine Transdermal Patch
  • Buprenorphine Transdermal Patch
  • Clonidine Transdermal Patch
  • Oxybutynin Transdermal Patch
  • Others
By Application
  • Hypertension
  • Contraception
  • Analgesia
  • Smoking Cessation
  • Angina
  • Hormone Replacement
By Distribution Channel
  • Online
  • Offline

By End User
  • Home Care Settings
  • Hospitals & Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Chronic Diseases
      • 3.2.2. Ease of Administration of Drugs
    • 3.3. Market Challenges
      • 3.3.1. Technical Barriers Related to Skin Irritation
    • 3.4. Market Trends
      • 3.4.1. Increasing Advantages over the Oral and Ingesting Treatments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Transdermal Drug Patches, by Type, Application, Distribution Channel, End User and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Transdermal Drug Patches (Value)
      • 5.2.1. Global Transdermal Drug Patches by: Type (Value)
        • 5.2.1.1. Fentanyl Transdermal Patch
        • 5.2.1.2. Nicotine Transdermal Patch
        • 5.2.1.3. Buprenorphine Transdermal Patch
        • 5.2.1.4. Clonidine Transdermal Patch
        • 5.2.1.5. Oxybutynin Transdermal Patch
        • 5.2.1.6. Others
      • 5.2.2. Global Transdermal Drug Patches by: Application (Value)
        • 5.2.2.1. Hypertension
        • 5.2.2.2. Contraception
        • 5.2.2.3. Analgesia
        • 5.2.2.4. Smoking Cessation
        • 5.2.2.5. Angina
        • 5.2.2.6. Hormone Replacement
      • 5.2.3. Global Transdermal Drug Patches by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Transdermal Drug Patches by: End User (Value)
        • 5.2.4.1. Home Care Settings
        • 5.2.4.2. Hospitals & Clinics
        • 5.2.4.3. Others
      • 5.2.5. Global Transdermal Drug Patches Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Transdermal Drug Patches (Volume)
      • 5.3.1. Global Transdermal Drug Patches by: Type (Volume)
        • 5.3.1.1. Fentanyl Transdermal Patch
        • 5.3.1.2. Nicotine Transdermal Patch
        • 5.3.1.3. Buprenorphine Transdermal Patch
        • 5.3.1.4. Clonidine Transdermal Patch
        • 5.3.1.5. Oxybutynin Transdermal Patch
        • 5.3.1.6. Others
      • 5.3.2. Global Transdermal Drug Patches by: Application (Volume)
        • 5.3.2.1. Hypertension
        • 5.3.2.2. Contraception
        • 5.3.2.3. Analgesia
        • 5.3.2.4. Smoking Cessation
        • 5.3.2.5. Angina
        • 5.3.2.6. Hormone Replacement
      • 5.3.3. Global Transdermal Drug Patches by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Transdermal Drug Patches by: End User (Volume)
        • 5.3.4.1. Home Care Settings
        • 5.3.4.2. Hospitals & Clinics
        • 5.3.4.3. Others
      • 5.3.5. Global Transdermal Drug Patches Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Transdermal Drug Patches (Price)
      • 5.4.1. Global Transdermal Drug Patches by: Type (Price)
  • 6. Transdermal Drug Patches: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Noven Pharmaceuticals, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Mylan (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Johnson & Johnson (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Agile Therapeutics (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Accrux Ltd. (Australia)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Teikoku Pharma USA (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Immune Pharmaceuticals (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Hercon Pharmaceuticals (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Pocono Coated Products (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Transdermal Drug Patches Sale, by Type, Application, Distribution Channel, End User and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Transdermal Drug Patches (Value)
      • 7.2.1. Global Transdermal Drug Patches by: Type (Value)
        • 7.2.1.1. Fentanyl Transdermal Patch
        • 7.2.1.2. Nicotine Transdermal Patch
        • 7.2.1.3. Buprenorphine Transdermal Patch
        • 7.2.1.4. Clonidine Transdermal Patch
        • 7.2.1.5. Oxybutynin Transdermal Patch
        • 7.2.1.6. Others
      • 7.2.2. Global Transdermal Drug Patches by: Application (Value)
        • 7.2.2.1. Hypertension
        • 7.2.2.2. Contraception
        • 7.2.2.3. Analgesia
        • 7.2.2.4. Smoking Cessation
        • 7.2.2.5. Angina
        • 7.2.2.6. Hormone Replacement
      • 7.2.3. Global Transdermal Drug Patches by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Transdermal Drug Patches by: End User (Value)
        • 7.2.4.1. Home Care Settings
        • 7.2.4.2. Hospitals & Clinics
        • 7.2.4.3. Others
      • 7.2.5. Global Transdermal Drug Patches Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Transdermal Drug Patches (Volume)
      • 7.3.1. Global Transdermal Drug Patches by: Type (Volume)
        • 7.3.1.1. Fentanyl Transdermal Patch
        • 7.3.1.2. Nicotine Transdermal Patch
        • 7.3.1.3. Buprenorphine Transdermal Patch
        • 7.3.1.4. Clonidine Transdermal Patch
        • 7.3.1.5. Oxybutynin Transdermal Patch
        • 7.3.1.6. Others
      • 7.3.2. Global Transdermal Drug Patches by: Application (Volume)
        • 7.3.2.1. Hypertension
        • 7.3.2.2. Contraception
        • 7.3.2.3. Analgesia
        • 7.3.2.4. Smoking Cessation
        • 7.3.2.5. Angina
        • 7.3.2.6. Hormone Replacement
      • 7.3.3. Global Transdermal Drug Patches by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Transdermal Drug Patches by: End User (Volume)
        • 7.3.4.1. Home Care Settings
        • 7.3.4.2. Hospitals & Clinics
        • 7.3.4.3. Others
      • 7.3.5. Global Transdermal Drug Patches Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Transdermal Drug Patches (Price)
      • 7.4.1. Global Transdermal Drug Patches by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Transdermal Drug Patches: by Type(USD Million)
  • Table 2. Transdermal Drug Patches Fentanyl Transdermal Patch , by Region USD Million (2013-2018)
  • Table 3. Transdermal Drug Patches Nicotine Transdermal Patch , by Region USD Million (2013-2018)
  • Table 4. Transdermal Drug Patches Buprenorphine Transdermal Patch , by Region USD Million (2013-2018)
  • Table 5. Transdermal Drug Patches Clonidine Transdermal Patch , by Region USD Million (2013-2018)
  • Table 6. Transdermal Drug Patches Oxybutynin Transdermal Patch , by Region USD Million (2013-2018)
  • Table 7. Transdermal Drug Patches Others , by Region USD Million (2013-2018)
  • Table 8. Transdermal Drug Patches: by Application(USD Million)
  • Table 9. Transdermal Drug Patches Hypertension , by Region USD Million (2013-2018)
  • Table 10. Transdermal Drug Patches Contraception , by Region USD Million (2013-2018)
  • Table 11. Transdermal Drug Patches Analgesia , by Region USD Million (2013-2018)
  • Table 12. Transdermal Drug Patches Smoking Cessation , by Region USD Million (2013-2018)
  • Table 13. Transdermal Drug Patches Angina , by Region USD Million (2013-2018)
  • Table 14. Transdermal Drug Patches Hormone Replacement , by Region USD Million (2013-2018)
  • Table 15. Transdermal Drug Patches: by Distribution Channel(USD Million)
  • Table 16. Transdermal Drug Patches Online , by Region USD Million (2013-2018)
  • Table 17. Transdermal Drug Patches Offline , by Region USD Million (2013-2018)
  • Table 18. Transdermal Drug Patches: by End User(USD Million)
  • Table 19. Transdermal Drug Patches Home Care Settings , by Region USD Million (2013-2018)
  • Table 20. Transdermal Drug Patches Hospitals & Clinics , by Region USD Million (2013-2018)
  • Table 21. Transdermal Drug Patches Others , by Region USD Million (2013-2018)
  • Table 22. South America Transdermal Drug Patches, by Country USD Million (2013-2018)
  • Table 23. South America Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 24. South America Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 25. South America Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 26. South America Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 27. Brazil Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 28. Brazil Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 29. Brazil Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 30. Brazil Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 31. Argentina Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 32. Argentina Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 33. Argentina Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 34. Argentina Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 35. Rest of South America Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 36. Rest of South America Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 37. Rest of South America Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 38. Rest of South America Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 39. Asia Pacific Transdermal Drug Patches, by Country USD Million (2013-2018)
  • Table 40. Asia Pacific Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 41. Asia Pacific Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 42. Asia Pacific Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 43. Asia Pacific Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 44. China Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 45. China Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 46. China Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 47. China Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 48. Japan Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 49. Japan Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 50. Japan Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 51. Japan Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 52. India Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 53. India Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 54. India Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 55. India Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 56. South Korea Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 57. South Korea Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 58. South Korea Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 59. South Korea Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 60. Taiwan Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 61. Taiwan Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 62. Taiwan Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 63. Taiwan Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 64. Australia Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 65. Australia Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 66. Australia Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 67. Australia Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 68. Rest of Asia-Pacific Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 70. Rest of Asia-Pacific Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 71. Rest of Asia-Pacific Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 72. Europe Transdermal Drug Patches, by Country USD Million (2013-2018)
  • Table 73. Europe Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 74. Europe Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 75. Europe Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 76. Europe Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 77. Germany Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 78. Germany Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 79. Germany Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 80. Germany Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 81. France Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 82. France Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 83. France Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 84. France Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 85. Italy Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 86. Italy Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 87. Italy Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 88. Italy Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 89. United Kingdom Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 90. United Kingdom Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 91. United Kingdom Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 92. United Kingdom Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 93. Netherlands Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 94. Netherlands Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 95. Netherlands Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 96. Netherlands Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 97. Rest of Europe Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 98. Rest of Europe Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 99. Rest of Europe Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 100. Rest of Europe Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 101. MEA Transdermal Drug Patches, by Country USD Million (2013-2018)
  • Table 102. MEA Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 103. MEA Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 104. MEA Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 105. MEA Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 106. Middle East Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 107. Middle East Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 108. Middle East Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 109. Middle East Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 110. Africa Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 111. Africa Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 112. Africa Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 113. Africa Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 114. North America Transdermal Drug Patches, by Country USD Million (2013-2018)
  • Table 115. North America Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 116. North America Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 117. North America Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 118. North America Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 119. United States Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 120. United States Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 121. United States Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 122. United States Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 123. Canada Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 124. Canada Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 125. Canada Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 126. Canada Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 127. Mexico Transdermal Drug Patches, by Type USD Million (2013-2018)
  • Table 128. Mexico Transdermal Drug Patches, by Application USD Million (2013-2018)
  • Table 129. Mexico Transdermal Drug Patches, by Distribution Channel USD Million (2013-2018)
  • Table 130. Mexico Transdermal Drug Patches, by End User USD Million (2013-2018)
  • Table 131. Transdermal Drug Patches Sales: by Type(K Units)
  • Table 132. Transdermal Drug Patches Sales Fentanyl Transdermal Patch , by Region K Units (2013-2018)
  • Table 133. Transdermal Drug Patches Sales Nicotine Transdermal Patch , by Region K Units (2013-2018)
  • Table 134. Transdermal Drug Patches Sales Buprenorphine Transdermal Patch , by Region K Units (2013-2018)
  • Table 135. Transdermal Drug Patches Sales Clonidine Transdermal Patch , by Region K Units (2013-2018)
  • Table 136. Transdermal Drug Patches Sales Oxybutynin Transdermal Patch , by Region K Units (2013-2018)
  • Table 137. Transdermal Drug Patches Sales Others , by Region K Units (2013-2018)
  • Table 138. Transdermal Drug Patches Sales: by Application(K Units)
  • Table 139. Transdermal Drug Patches Sales Hypertension , by Region K Units (2013-2018)
  • Table 140. Transdermal Drug Patches Sales Contraception , by Region K Units (2013-2018)
  • Table 141. Transdermal Drug Patches Sales Analgesia , by Region K Units (2013-2018)
  • Table 142. Transdermal Drug Patches Sales Smoking Cessation , by Region K Units (2013-2018)
  • Table 143. Transdermal Drug Patches Sales Angina , by Region K Units (2013-2018)
  • Table 144. Transdermal Drug Patches Sales Hormone Replacement , by Region K Units (2013-2018)
  • Table 145. Transdermal Drug Patches Sales: by Distribution Channel(K Units)
  • Table 146. Transdermal Drug Patches Sales Online , by Region K Units (2013-2018)
  • Table 147. Transdermal Drug Patches Sales Offline , by Region K Units (2013-2018)
  • Table 148. Transdermal Drug Patches Sales: by End User(K Units)
  • Table 149. Transdermal Drug Patches Sales Home Care Settings , by Region K Units (2013-2018)
  • Table 150. Transdermal Drug Patches Sales Hospitals & Clinics , by Region K Units (2013-2018)
  • Table 151. Transdermal Drug Patches Sales Others , by Region K Units (2013-2018)
  • Table 152. South America Transdermal Drug Patches Sales, by Country K Units (2013-2018)
  • Table 153. South America Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 154. South America Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 155. South America Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 156. South America Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 157. Brazil Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 158. Brazil Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 159. Brazil Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 160. Brazil Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 161. Argentina Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 162. Argentina Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 163. Argentina Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 164. Argentina Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 165. Rest of South America Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 166. Rest of South America Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 167. Rest of South America Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 168. Rest of South America Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 169. Asia Pacific Transdermal Drug Patches Sales, by Country K Units (2013-2018)
  • Table 170. Asia Pacific Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 171. Asia Pacific Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 172. Asia Pacific Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 173. Asia Pacific Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 174. China Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 175. China Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 176. China Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 177. China Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 178. Japan Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 179. Japan Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 180. Japan Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 181. Japan Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 182. India Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 183. India Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 184. India Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 185. India Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 186. South Korea Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 187. South Korea Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 188. South Korea Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 189. South Korea Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 190. Taiwan Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 191. Taiwan Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 192. Taiwan Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 193. Taiwan Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 194. Australia Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 195. Australia Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 196. Australia Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 197. Australia Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 198. Rest of Asia-Pacific Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 199. Rest of Asia-Pacific Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 200. Rest of Asia-Pacific Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 201. Rest of Asia-Pacific Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 202. Europe Transdermal Drug Patches Sales, by Country K Units (2013-2018)
  • Table 203. Europe Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 204. Europe Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 205. Europe Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 206. Europe Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 207. Germany Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 208. Germany Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 209. Germany Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 210. Germany Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 211. France Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 212. France Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 213. France Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 214. France Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 215. Italy Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 216. Italy Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 217. Italy Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 218. Italy Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 219. United Kingdom Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 220. United Kingdom Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 221. United Kingdom Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 222. United Kingdom Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 223. Netherlands Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 224. Netherlands Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 225. Netherlands Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 226. Netherlands Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 227. Rest of Europe Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 228. Rest of Europe Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 229. Rest of Europe Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 230. Rest of Europe Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 231. MEA Transdermal Drug Patches Sales, by Country K Units (2013-2018)
  • Table 232. MEA Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 233. MEA Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 234. MEA Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 235. MEA Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 236. Middle East Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 237. Middle East Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 238. Middle East Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 239. Middle East Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 240. Africa Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 241. Africa Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 242. Africa Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 243. Africa Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 244. North America Transdermal Drug Patches Sales, by Country K Units (2013-2018)
  • Table 245. North America Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 246. North America Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 247. North America Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 248. North America Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 249. United States Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 250. United States Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 251. United States Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 252. United States Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 253. Canada Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 254. Canada Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 255. Canada Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 256. Canada Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 257. Mexico Transdermal Drug Patches Sales, by Type K Units (2013-2018)
  • Table 258. Mexico Transdermal Drug Patches Sales, by Application K Units (2013-2018)
  • Table 259. Mexico Transdermal Drug Patches Sales, by Distribution Channel K Units (2013-2018)
  • Table 260. Mexico Transdermal Drug Patches Sales, by End User K Units (2013-2018)
  • Table 261. Transdermal Drug Patches: by Type(USD/Units)
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Transdermal Drug Patches: by Type(USD Million)
  • Table 273. Transdermal Drug Patches Fentanyl Transdermal Patch , by Region USD Million (2019-2024)
  • Table 274. Transdermal Drug Patches Nicotine Transdermal Patch , by Region USD Million (2019-2024)
  • Table 275. Transdermal Drug Patches Buprenorphine Transdermal Patch , by Region USD Million (2019-2024)
  • Table 276. Transdermal Drug Patches Clonidine Transdermal Patch , by Region USD Million (2019-2024)
  • Table 277. Transdermal Drug Patches Oxybutynin Transdermal Patch , by Region USD Million (2019-2024)
  • Table 278. Transdermal Drug Patches Others , by Region USD Million (2019-2024)
  • Table 279. Transdermal Drug Patches: by Application(USD Million)
  • Table 280. Transdermal Drug Patches Hypertension , by Region USD Million (2019-2024)
  • Table 281. Transdermal Drug Patches Contraception , by Region USD Million (2019-2024)
  • Table 282. Transdermal Drug Patches Analgesia , by Region USD Million (2019-2024)
  • Table 283. Transdermal Drug Patches Smoking Cessation , by Region USD Million (2019-2024)
  • Table 284. Transdermal Drug Patches Angina , by Region USD Million (2019-2024)
  • Table 285. Transdermal Drug Patches Hormone Replacement , by Region USD Million (2019-2024)
  • Table 286. Transdermal Drug Patches: by Distribution Channel(USD Million)
  • Table 287. Transdermal Drug Patches Online , by Region USD Million (2019-2024)
  • Table 288. Transdermal Drug Patches Offline , by Region USD Million (2019-2024)
  • Table 289. Transdermal Drug Patches: by End User(USD Million)
  • Table 290. Transdermal Drug Patches Home Care Settings , by Region USD Million (2019-2024)
  • Table 291. Transdermal Drug Patches Hospitals & Clinics , by Region USD Million (2019-2024)
  • Table 292. Transdermal Drug Patches Others , by Region USD Million (2019-2024)
  • Table 293. South America Transdermal Drug Patches, by Country USD Million (2019-2024)
  • Table 294. South America Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 295. South America Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 296. South America Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 297. South America Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 298. Brazil Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 299. Brazil Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 300. Brazil Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 301. Brazil Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 302. Argentina Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 303. Argentina Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 304. Argentina Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 305. Argentina Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 306. Rest of South America Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 307. Rest of South America Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 308. Rest of South America Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 309. Rest of South America Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 310. Asia Pacific Transdermal Drug Patches, by Country USD Million (2019-2024)
  • Table 311. Asia Pacific Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 312. Asia Pacific Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 313. Asia Pacific Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 314. Asia Pacific Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 315. China Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 316. China Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 317. China Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 318. China Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 319. Japan Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 320. Japan Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 321. Japan Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 322. Japan Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 323. India Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 324. India Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 325. India Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 326. India Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 327. South Korea Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 328. South Korea Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 329. South Korea Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 330. South Korea Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 331. Taiwan Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 332. Taiwan Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 333. Taiwan Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 334. Taiwan Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 335. Australia Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 336. Australia Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 337. Australia Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 338. Australia Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 339. Rest of Asia-Pacific Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 340. Rest of Asia-Pacific Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 341. Rest of Asia-Pacific Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 342. Rest of Asia-Pacific Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 343. Europe Transdermal Drug Patches, by Country USD Million (2019-2024)
  • Table 344. Europe Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 345. Europe Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 346. Europe Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 347. Europe Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 348. Germany Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 349. Germany Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 350. Germany Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 351. Germany Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 352. France Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 353. France Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 354. France Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 355. France Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 356. Italy Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 357. Italy Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 358. Italy Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 359. Italy Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 360. United Kingdom Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 361. United Kingdom Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 362. United Kingdom Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 363. United Kingdom Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 364. Netherlands Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 365. Netherlands Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 366. Netherlands Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 367. Netherlands Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 368. Rest of Europe Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 369. Rest of Europe Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 370. Rest of Europe Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 371. Rest of Europe Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 372. MEA Transdermal Drug Patches, by Country USD Million (2019-2024)
  • Table 373. MEA Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 374. MEA Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 375. MEA Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 376. MEA Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 377. Middle East Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 378. Middle East Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 379. Middle East Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 380. Middle East Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 381. Africa Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 382. Africa Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 383. Africa Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 384. Africa Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 385. North America Transdermal Drug Patches, by Country USD Million (2019-2024)
  • Table 386. North America Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 387. North America Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 388. North America Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 389. North America Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 390. United States Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 391. United States Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 392. United States Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 393. United States Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 394. Canada Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 395. Canada Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 396. Canada Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 397. Canada Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 398. Mexico Transdermal Drug Patches, by Type USD Million (2019-2024)
  • Table 399. Mexico Transdermal Drug Patches, by Application USD Million (2019-2024)
  • Table 400. Mexico Transdermal Drug Patches, by Distribution Channel USD Million (2019-2024)
  • Table 401. Mexico Transdermal Drug Patches, by End User USD Million (2019-2024)
  • Table 402. Transdermal Drug Patches Sales: by Type(K Units)
  • Table 403. Transdermal Drug Patches Sales Fentanyl Transdermal Patch , by Region K Units (2019-2024)
  • Table 404. Transdermal Drug Patches Sales Nicotine Transdermal Patch , by Region K Units (2019-2024)
  • Table 405. Transdermal Drug Patches Sales Buprenorphine Transdermal Patch , by Region K Units (2019-2024)
  • Table 406. Transdermal Drug Patches Sales Clonidine Transdermal Patch , by Region K Units (2019-2024)
  • Table 407. Transdermal Drug Patches Sales Oxybutynin Transdermal Patch , by Region K Units (2019-2024)
  • Table 408. Transdermal Drug Patches Sales Others , by Region K Units (2019-2024)
  • Table 409. Transdermal Drug Patches Sales: by Application(K Units)
  • Table 410. Transdermal Drug Patches Sales Hypertension , by Region K Units (2019-2024)
  • Table 411. Transdermal Drug Patches Sales Contraception , by Region K Units (2019-2024)
  • Table 412. Transdermal Drug Patches Sales Analgesia , by Region K Units (2019-2024)
  • Table 413. Transdermal Drug Patches Sales Smoking Cessation , by Region K Units (2019-2024)
  • Table 414. Transdermal Drug Patches Sales Angina , by Region K Units (2019-2024)
  • Table 415. Transdermal Drug Patches Sales Hormone Replacement , by Region K Units (2019-2024)
  • Table 416. Transdermal Drug Patches Sales: by Distribution Channel(K Units)
  • Table 417. Transdermal Drug Patches Sales Online , by Region K Units (2019-2024)
  • Table 418. Transdermal Drug Patches Sales Offline , by Region K Units (2019-2024)
  • Table 419. Transdermal Drug Patches Sales: by End User(K Units)
  • Table 420. Transdermal Drug Patches Sales Home Care Settings , by Region K Units (2019-2024)
  • Table 421. Transdermal Drug Patches Sales Hospitals & Clinics , by Region K Units (2019-2024)
  • Table 422. Transdermal Drug Patches Sales Others , by Region K Units (2019-2024)
  • Table 423. South America Transdermal Drug Patches Sales, by Country K Units (2019-2024)
  • Table 424. South America Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 425. South America Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 426. South America Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 427. South America Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 428. Brazil Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 429. Brazil Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 430. Brazil Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 431. Brazil Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 432. Argentina Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 433. Argentina Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 434. Argentina Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 435. Argentina Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 436. Rest of South America Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 437. Rest of South America Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 438. Rest of South America Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 439. Rest of South America Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 440. Asia Pacific Transdermal Drug Patches Sales, by Country K Units (2019-2024)
  • Table 441. Asia Pacific Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 442. Asia Pacific Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 443. Asia Pacific Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 444. Asia Pacific Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 445. China Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 446. China Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 447. China Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 448. China Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 449. Japan Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 450. Japan Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 451. Japan Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 452. Japan Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 453. India Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 454. India Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 455. India Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 456. India Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 457. South Korea Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 458. South Korea Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 459. South Korea Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 460. South Korea Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 461. Taiwan Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 462. Taiwan Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 463. Taiwan Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 464. Taiwan Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 465. Australia Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 466. Australia Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 467. Australia Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 468. Australia Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 469. Rest of Asia-Pacific Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 470. Rest of Asia-Pacific Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 471. Rest of Asia-Pacific Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 472. Rest of Asia-Pacific Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 473. Europe Transdermal Drug Patches Sales, by Country K Units (2019-2024)
  • Table 474. Europe Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 475. Europe Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 476. Europe Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 477. Europe Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 478. Germany Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 479. Germany Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 480. Germany Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 481. Germany Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 482. France Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 483. France Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 484. France Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 485. France Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 486. Italy Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 487. Italy Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 488. Italy Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 489. Italy Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 490. United Kingdom Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 491. United Kingdom Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 492. United Kingdom Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 493. United Kingdom Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 494. Netherlands Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 495. Netherlands Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 496. Netherlands Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 497. Netherlands Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 498. Rest of Europe Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 499. Rest of Europe Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 500. Rest of Europe Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 501. Rest of Europe Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 502. MEA Transdermal Drug Patches Sales, by Country K Units (2019-2024)
  • Table 503. MEA Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 504. MEA Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 505. MEA Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 506. MEA Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 507. Middle East Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 508. Middle East Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 509. Middle East Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 510. Middle East Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 511. Africa Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 512. Africa Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 513. Africa Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 514. Africa Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 515. North America Transdermal Drug Patches Sales, by Country K Units (2019-2024)
  • Table 516. North America Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 517. North America Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 518. North America Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 519. North America Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 520. United States Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 521. United States Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 522. United States Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 523. United States Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 524. Canada Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 525. Canada Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 526. Canada Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 527. Canada Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 528. Mexico Transdermal Drug Patches Sales, by Type K Units (2019-2024)
  • Table 529. Mexico Transdermal Drug Patches Sales, by Application K Units (2019-2024)
  • Table 530. Mexico Transdermal Drug Patches Sales, by Distribution Channel K Units (2019-2024)
  • Table 531. Mexico Transdermal Drug Patches Sales, by End User K Units (2019-2024)
  • Table 532. Transdermal Drug Patches: by Type(USD/Units)
  • Table 533. Research Programs/Design for This Report
  • Table 534. Key Data Information from Secondary Sources
  • Table 535. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Transdermal Drug Patches: by Type USD Million (2013-2018)
  • Figure 5. Global Transdermal Drug Patches: by Application USD Million (2013-2018)
  • Figure 6. Global Transdermal Drug Patches: by Distribution Channel USD Million (2013-2018)
  • Figure 7. Global Transdermal Drug Patches: by End User USD Million (2013-2018)
  • Figure 8. South America Transdermal Drug Patches Share (%), by Country
  • Figure 9. Asia Pacific Transdermal Drug Patches Share (%), by Country
  • Figure 10. Europe Transdermal Drug Patches Share (%), by Country
  • Figure 11. MEA Transdermal Drug Patches Share (%), by Country
  • Figure 12. North America Transdermal Drug Patches Share (%), by Country
  • Figure 13. Global Transdermal Drug Patches: by Type K Units (2013-2018)
  • Figure 14. Global Transdermal Drug Patches: by Application K Units (2013-2018)
  • Figure 15. Global Transdermal Drug Patches: by Distribution Channel K Units (2013-2018)
  • Figure 16. Global Transdermal Drug Patches: by End User K Units (2013-2018)
  • Figure 17. South America Transdermal Drug Patches Share (%), by Country
  • Figure 18. Asia Pacific Transdermal Drug Patches Share (%), by Country
  • Figure 19. Europe Transdermal Drug Patches Share (%), by Country
  • Figure 20. MEA Transdermal Drug Patches Share (%), by Country
  • Figure 21. North America Transdermal Drug Patches Share (%), by Country
  • Figure 22. Global Transdermal Drug Patches: by Type USD/Units (2013-2018)
  • Figure 23. Global Transdermal Drug Patches share by Players 2018 (%)
  • Figure 24. Global Transdermal Drug Patches share by Players (Top 3) 2018(%)
  • Figure 25. Global Transdermal Drug Patches share by Players (Top 5) 2018(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Noven Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Noven Pharmaceuticals, Inc. (United States) Revenue: by Geography 2018
  • Figure 29. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 30. Mylan (United States) Revenue: by Geography 2018
  • Figure 31. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Novartis (Switzerland) Revenue: by Geography 2018
  • Figure 33. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 34. Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 35. Agile Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 36. Agile Therapeutics (United States) Revenue: by Geography 2018
  • Figure 37. Accrux Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 38. Accrux Ltd. (Australia) Revenue: by Geography 2018
  • Figure 39. Teikoku Pharma USA (United States) Revenue, Net Income and Gross profit
  • Figure 40. Teikoku Pharma USA (United States) Revenue: by Geography 2018
  • Figure 41. Immune Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 42. Immune Pharmaceuticals (United States) Revenue: by Geography 2018
  • Figure 43. Hercon Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 44. Hercon Pharmaceuticals (United States) Revenue: by Geography 2018
  • Figure 45. Pocono Coated Products (United States) Revenue, Net Income and Gross profit
  • Figure 46. Pocono Coated Products (United States) Revenue: by Geography 2018
  • Figure 47. Global Transdermal Drug Patches: by Type USD Million (2019-2024)
  • Figure 48. Global Transdermal Drug Patches: by Application USD Million (2019-2024)
  • Figure 49. Global Transdermal Drug Patches: by Distribution Channel USD Million (2019-2024)
  • Figure 50. Global Transdermal Drug Patches: by End User USD Million (2019-2024)
  • Figure 51. South America Transdermal Drug Patches Share (%), by Country
  • Figure 52. Asia Pacific Transdermal Drug Patches Share (%), by Country
  • Figure 53. Europe Transdermal Drug Patches Share (%), by Country
  • Figure 54. MEA Transdermal Drug Patches Share (%), by Country
  • Figure 55. North America Transdermal Drug Patches Share (%), by Country
  • Figure 56. Global Transdermal Drug Patches: by Type K Units (2019-2024)
  • Figure 57. Global Transdermal Drug Patches: by Application K Units (2019-2024)
  • Figure 58. Global Transdermal Drug Patches: by Distribution Channel K Units (2019-2024)
  • Figure 59. Global Transdermal Drug Patches: by End User K Units (2019-2024)
  • Figure 60. South America Transdermal Drug Patches Share (%), by Country
  • Figure 61. Asia Pacific Transdermal Drug Patches Share (%), by Country
  • Figure 62. Europe Transdermal Drug Patches Share (%), by Country
  • Figure 63. MEA Transdermal Drug Patches Share (%), by Country
  • Figure 64. North America Transdermal Drug Patches Share (%), by Country
  • Figure 65. Global Transdermal Drug Patches: by Type USD/Units (2019-2024)
List of companies from research coverage that are profiled in the study
  • Noven Pharmaceuticals, Inc. (United States)
  • Mylan (United States)
  • Novartis (Switzerland)
  • Johnson & Johnson (United States)
  • Agile Therapeutics (United States)
  • Accrux Ltd. (Australia)
  • Teikoku Pharma USA (United States)
  • Immune Pharmaceuticals (United States)
  • Hercon Pharmaceuticals (United States)
  • Pocono Coated Products (United States)
Additional players considered in the study are as follows:
DURECT Corporation (United States) , Xel Pharmaceuticals (United States)
Select User Access Type

Key Highlights of Report


Nov 2019 201 Pages 83 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Transdermal Drug Patches Market Quantitative research analysis
Global Transdermal Drug Patches Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Transdermal Drug Patches Market Report?

Have a Query? Click Here

Other Related Reports

Meropenem Comprehensive Study by Application (Skin and Skin Structure Infection, Intra-abdominal infection, Meningitis, Nosocomial Infection, Others), End Users (Adult, Pediatric), Distribution Chann...
$ 3450
Cardiac Troponin Comprehensive Study by Type (CTn T, CTn I, TnC), Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others Applications), End User (Laboratory Tes...
$ 3350
Branded Generics Comprehensive Study by Type (Value Added Branded Generics, Trade (Brand) Named Generics), Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Others)...
$ 3650
Insulin Glargine Comprehensive Study by Application (Type 1 Diabetes (T1D), Type 2 Diabetes (T2D)), Forms (Liquid, Tablet, Syrup, Cream, Gel), Side Effect (Rash, Hives, Itching, Wheezing), Distribut...
$ 3800
Topical Pain Relief Comprehensive Study by Type (Prescription Pain Relief Products, Over-the-counter (OTC) Pain Relief Products), Application (Pets, Mammals, Farm Animals), Distribution Channel (Phar...
$ 3650
Atenolol Tablets Comprehensive Study by Application (Hypertension, Angina, Arrhythmias), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Prescription Mode (Prescript...
$ 3450